Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.

Venken K, Decruy T, Aspeslagh S, Van Calenbergh S, Lambrecht BN, Elewaut D.

J Immunol. 2013 Sep 1;191(5):2174-83. doi: 10.4049/jimmunol.1300562. Epub 2013 Jul 29.

2.

Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.

Goubier A, Vocanson M, Macari C, Poyet G, Herbelin A, Nicolas JF, Dubois B, Kaiserlian D.

J Invest Dermatol. 2013 Apr;133(4):980-7. doi: 10.1038/jid.2012.404. Epub 2012 Nov 29.

3.

mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.

Huijts CM, Schneiders FL, Garcia-Vallejo JJ, Verheul HM, de Gruijl TD, van der Vliet HJ.

J Immunol. 2015 Sep 1;195(5):2038-45. doi: 10.4049/jimmunol.1402710. Epub 2015 Aug 3.

PMID:
26238486
4.

Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.

Rosalia RA, Štěpánek I, Polláková V, Šímová J, Bieblová J, Indrová M, Moravcová S, Přibylová H, Bontkes HJ, Bubeník J, Sparwasser T, Reiniš M.

Immunobiology. 2013 Jun;218(6):851-9. doi: 10.1016/j.imbio.2012.10.012. Epub 2012 Oct 26.

PMID:
23182710
5.

Cognate interaction with iNKT cells expands IL-10-producing B regulatory cells.

Vomhof-DeKrey EE, Yates J, Hägglöf T, Lanthier P, Amiel E, Veerapen N, Besra GS, Karlsson MC, Leadbetter EA.

Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12474-9. doi: 10.1073/pnas.1504790112. Epub 2015 Sep 21.

6.

CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens.

Hayworth JL, Mazzuca DM, Maleki Vareki S, Welch I, McCormick JK, Haeryfar SM.

Immunol Cell Biol. 2012 Aug;90(7):699-709. doi: 10.1038/icb.2011.90. Epub 2011 Nov 1.

PMID:
22041925
7.

Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities.

Wu L, Gabriel CL, Parekh VV, Van Kaer L.

Tissue Antigens. 2009 Jun;73(6):535-45. doi: 10.1111/j.1399-0039.2009.01256.x. Epub 2009 Apr 8. Review.

PMID:
19392798
8.

Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.

Uemura Y, Liu TY, Narita Y, Suzuki M, Nakatsuka R, Araki T, Matsumoto M, Iwai LK, Hirosawa N, Matsuoka Y, Murakami M, Kimura T, Hase M, Kohno H, Sasaki Y, Ichihara Y, Ishihara O, Kikuchi H, Sakamoto Y, Jiao SC, Senju S, Sonoda Y.

J Immunol. 2009 Jul 1;183(1):201-8. doi: 10.4049/jimmunol.0900873.

9.

The glycolipid exoantigen derived from Chlamydia muridarum activates invariant natural killer T cells.

Peng Y, Zhao L, Shekhar S, Liu L, Wang H, Chen Q, Gao X, Yang X, Zhao W.

Cell Mol Immunol. 2012 Jul;9(4):361-6. doi: 10.1038/cmi.2012.19. Epub 2012 Jun 25.

10.

Turned on by danger: activation of CD1d-restricted invariant natural killer T cells.

Lawson V.

Immunology. 2012 Sep;137(1):20-7. doi: 10.1111/j.1365-2567.2012.03612.x. Review.

11.

Protection from type 1 diabetes by invariant NK T cells requires the activity of CD4+CD25+ regulatory T cells.

Ly D, Mi QS, Hussain S, Delovitch TL.

J Immunol. 2006 Sep 15;177(6):3695-704.

12.

Contact-dependent interference with invariant NKT cell activation by herpes simplex virus-infected cells.

Bosnjak L, Sahlström P, Paquin-Proulx D, Leeansyah E, Moll M, Sandberg JK.

J Immunol. 2012 Jun 15;188(12):6216-24. doi: 10.4049/jimmunol.1100218. Epub 2012 May 11.

13.

Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.

Hogan AE, O'Reilly V, Dunne MR, Dere RT, Zeng SG, O'Brien C, Amu S, Fallon PG, Exley MA, O'Farrelly C, Zhu X, Doherty DG.

Clin Immunol. 2011 Aug;140(2):196-207. doi: 10.1016/j.clim.2011.03.016. Epub 2011 Apr 13.

PMID:
21493160
14.

Role of marginal zone B lymphocytes in invariant NKT cell activation.

Bialecki E, Paget C, Fontaine J, Capron M, Trottein F, Faveeuw C.

J Immunol. 2009 May 15;182(10):6105-13. doi: 10.4049/jimmunol.0802273.

15.

IFN-gamma-producing human invariant NKT cells promote tumor-associated antigen-specific cytotoxic T cell responses.

Moreno M, Molling JW, von Mensdorff-Pouilly S, Verheijen RH, Hooijberg E, Kramer D, Reurs AW, van den Eertwegh AJ, von Blomberg BM, Scheper RJ, Bontkes HJ.

J Immunol. 2008 Aug 15;181(4):2446-54.

16.

Natural killer T cells constitutively expressing the interleukin-2 receptor α chain early in life are primed to respond to lower antigenic stimulation.

Ladd M, Sharma A, Huang Q, Wang AY, Xu L, Genowati I, Levings MK, Lavoie PM.

Immunology. 2010 Oct;131(2):289-99. doi: 10.1111/j.1365-2567.2010.03304.x.

17.

Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.

Taylor AL, Llewelyn MJ.

J Immunol. 2010 Dec 1;185(11):6591-8. doi: 10.4049/jimmunol.1002416. Epub 2010 Nov 3.

18.

Invariant NKT cells inhibit development of the Th17 lineage.

Mars LT, Araujo L, Kerschen P, Diem S, Bourgeois E, Van LP, Carrié N, Dy M, Liblau RS, Herbelin A.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6238-43. doi: 10.1073/pnas.0809317106. Epub 2009 Mar 26.

19.

Unique interplay between sugar and lipid in determining the antigenic potency of bacterial antigens for NKT cells.

Girardi E, Yu ED, Li Y, Tarumoto N, Pei B, Wang J, Illarionov P, Kinjo Y, Kronenberg M, Zajonc DM.

PLoS Biol. 2011 Nov;9(11):e1001189. doi: 10.1371/journal.pbio.1001189. Epub 2011 Nov 1.

20.

iNKT cells in microbial immunity: recognition of microbial glycolipids.

Kinjo Y, Ueno K.

Microbiol Immunol. 2011 Jul;55(7):472-82. doi: 10.1111/j.1348-0421.2011.00338.x. Review.

Items per page

Supplemental Content

Write to the Help Desk